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OBJECTIVES This study was undertaken to investigate the relationship between pulmonary hypertension
and exercise performance in patients with heart failure.
BACKGROUND The exercise capacity of patients with heart failure is frequently reduced. Pulmonary
hypertension may contribute to this exercise intolerance by impairing blood flow through the
pulmonary circulation.
METHOD Three hundred twenty patients with heart failure underwent upright treadmill exercise testing
with hemodynamic monitoring. The incidence of pulmonary hypertension and the relation-
ship between pulmonary vascular resistance (PVR) and exercise cardiac output and minute
oxygen consumption (VO2) were examined.
RESULTS Pulmonary vascular resistance was normal (,1.5 Wood Units; Group 1) in 28% of the
patients, mildly elevated (1.5 to 2.49 Wood Units; Group 2) in 36%, moderately elevated (2.5
to 3.49 Wood Units; Group 3) in 17% and severely elevated (.3.5 Wood Units; Group 4)
in 19%. Increasing PVR was associated with significantly lower peak exercise VO2 (Group 1:
13.9 6 3.7; 2:13.7 6 3.4; 3: 11.8 6 2.4; 4: 11.5 6 2.6 L/min, p , 0.01 Groups 3 and 4 vs.
1) and lower peak exercise cardiac output (Group 1: 10.0 6 2.8, 2:9.0 6 3.0; 3: 7.4 6 2.1;
4: 6.3 6 2.0 L/min, p , 0.05, Groups 2, 3 and 4 vs. 1). The pulmonary wedge pressure
decreased during exercise, consistent with impaired left ventricular filling, in 36% of patients
with severe pulmonary hypertension (Group 4) versus only 13% of patients with normal PVR
(p , 0.01).
CONCLUSIONS Pulmonary vascular resistance is frequently increased in heart failure and is associated with a
reduced cardiac output response to exercise, suggesting that pulmonary hypertension impairs
exercise performance in heart failure. (J Am Coll Cardiol 1999;34:1802–6) © 1999 by the
American College of Cardiology
Exercise intolerance is a serious and almost universal prob-
lem in patients with chronic heart failure (1,2). In the past,
this problem has been attributed primarily to left ventricular
dysfunction, impaired skeletal muscle arteriolar vasodilation
and changes in skeletal muscle characteristics, possibly due
to muscle deconditioning (1–4). Relatively little attention
has been focused on the pulmonary circulation and right
ventricle, aside from reports of a correlation between right
ventricular function, pulmonary artery pressures and maxi-
mal exercise performance (5).
Pulmonary hypertension is a well-established complica-
tion of chronic heart failure (6,7). During exercise, excessive
pulmonary vascular resistance theoretically could impair the
delivery of blood to the left ventricle and thereby attenuate
the cardiac output response to exercise. Therefore, pulmo-
nary hypertension may be an important contributor to
exercise intolerance in heart failure.
This study was undertaken to investigate the relationship
between pulmonary hypertension and exercise performance
in heart failure. Specifically, we sought to define the
incidence of pulmonary hypertension in ambulatory patients
with heart failure. Second, we examined the relationship
between pulmonary vascular resistance (PVR), peak exercise
minute oxygen consumption (VO2) and the cardiac output
response to exercise.
METHODS
Patient population. The study population consisted of all
ambulatory patients with heart failure who underwent right
heart catheterization with exercise studies between Decem-
ber 1993 and March 1997. During that time period, right
heart catheterization with exercise was used routinely to
investigate exercise performance in patients referred to the
Vanderbilt Heart Failure and Heart Transplantation Pro-
grams. Patients were excluded if their ejection fraction was
more than 40%, if they were dependent on inotropic or
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mechanical support, if they were limited by angina during
exercise, or if they exhibited arterial oxygen desaturation
during exercise. A total of 320 patients were studied.
Average age of these patients was 52 6 10 years (range: 21
to 75 years). Seventy-four percent of the patients were men.
There were approximately equal proportions of patients
with ischemic and dilated cardiomyopathy. Left ventricular
ejection fraction was 23% 6 9% (range: 8% to 40%).
Overall, mean peak VO2 was 13.0 6 3.4 ml/min/kg. All
patients had exertional dyspnea, fatigue or both and were
classified according to New York Heart Association classi-
fication between class II to IV.
Protocol. On the day of the study, patients arrived in the
morning at Vanderbilt University Heart Failure and Heart
Transplantation Program’s catheterization procedure labo-
ratory having fasted overnight. A 7F Swan Ganz thermodi-
lution catheter was inserted percutaneously through an
internal jugular vein (brachial vein if internal jugular can-
nulation unsuccessful) and positioned in the pulmonary
artery.
Supine central hemodynamic measurements were ob-
tained that included pulmonary artery pressure, right atrial
pressure and pulmonary capillary wedge pressure. Blood
pressure was measured by a sphygmomanometer. Supine
cardiac output was also determined by thermodilution, in
triplicate. Blood samples were drawn from the pulmonary
artery for measurement of hemoglobin oxygen (O2) satura-
tion.
Patients then stood up on the treadmill and were con-
nected to a Medgraphics Cardio O2 Metabolic Cart. The
patient’s left index finger was attached to a pulse oximeter to
continuously monitor arterial hemoglobin O2 saturation.
The patient then began exercising on the treadmill, using
a modified Naughton protocol. Each exercise stage lasted
3 min. Speed and grade for each stage was as follows: 1
(1 mph, 0), 2 (2 mph, 0), 3 (2 mph, 3.5), 4 (2 mph, 7), 5
(2 mph, 10.5), 6 (2 mph, 14), 7 (2 mph, 17.5), 8 (2 mph,
21), 9 (2.5 mph, 21), 10 (3 mph, 21). All patients continued
exercising until symptoms of dyspnea or fatigue, or both,
forced them to stop. Central hemodynamic measurements
and respiratory gas exchange analysis were recorded contin-
uously throughout exercise. Blood sampling from the pul-
monary artery was performed during the last 45 s of each
stage.
Measured variables. Arterial hemoglobin concentration
was measured by Coulter Counter; hemoglobin O2 satura-
tion was measured with a Instrumentation Laboratories 282
Co-oximeter precalibrated with human blood. Blood O2
content was calculated as the product of hemoglobin, 1.34
ml O2/g hemoglobin and percent O2 saturation. Oxygen
extraction was calculated as the ratio of the arteriovenous O2
difference and arterial O2 content.
Derived variables. The following hemodynamic variables
were calculated using standard formulas: mean arterial
pressure, arteriovenous O2 difference and systemic vascular
resistance. Mean arterial pressure was calculated as diastolic
pressure 1 one-third of the pulse pressure. Total pulmonary
resistance was calculated as the mean pulmonary artery
pressure divided by the cardiac output. Pulmonary vascular
resistance was calculated as (mean pulmonary artery
pressure-pulmonary wedge pressure)/cardiac output. Ther-
modilution cardiac output values were obtained with the
patient in the resting supine position whereas Fick cardiac
output values were calculated during upright exercise.
Statistical analysis. Initially descriptive analyses were per-
formed on all the patients. The patients were then divided
into four groups. Group 1 consisted of patients with normal
resting PVR (,1.5 Wood Units). Group 2 had PVR
between 1.5 and 2.49 Wood Units, Group 3 had pulmonary
vascular resistance between 2.5 and 3.49 Wood Units and
Group 4 had .3.5 Wood Units. These groups were
compared for various clinical, hemodynamic and ventilatory
parameters. Categorical variables were compared using chi-
square test and continuous variables using analysis of vari-
ance (ANOVA). A two-tailed p value of ,0.05 was used for
statistical significance. When continuous variables were
found to be significantly different using ANOVA and a p
value ,0.05, post hoc analyzes were performed with un-
paired t testing using Bonferonni correction to detect
differences between individual classes. Continuous variables
are presented as mean 6 SD and categorical variables as
percentages. SPSS for Windows Release 7 (SPSS Inc.,
Chicago, Illinois) was used for statistical calculations.
RESULTS
Supine resting and peak exercise hemodynamic responses
for the entire population are summarized in Tables 1 and 2.
Resting pulmonary artery pressure averaged 28 6
11 mm Hg, pulmonary wedge pressure 18 6 9 mm Hg,
total pulmonary resistance 7.06 6 4.28 Wood Units and
PVR 2.45 6 1.57 Wood Units. With exercise, patients
achieved peak VO2 levels of 13.0 6 3.4 ml/min/kg. At peak
exercise, PVR was unchanged from resting levels (2.41 6
1.52 Wood Units).
Pulmonary vascular resistance. Resting PVR was normal
(,1.5 Wood Units; Group 1) in 28% of the patients, mildly
elevated (1.5–2.49 Wood Units; Group 2) in 36%, moder-
ately elevated (2.5–3.49 Wood Units; Group 3) in 17%, and
severely elevated (.3.5 Wood Units; Group 4) in 19%.
There were no significant differences in these group in their
Abbreviations and Acronyms
ANOVA 5 analysis of variance
O2 5 oxygen
PVR 5 pulmonary vascular resistance
VO2 5 minute oxygen consumption
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age, etiology of heart failure and baseline ejection fractions
(Table 1).
Increasing PVR was associated with significantly lower
resting cardiac output (Group 1: 5.2 6 1.3; 2: 4.6 6 1.0; 3:
4.2 6 1.2; 4: 3.3 6 0.7 L/min, p , 0.01 Groups 2, 3 and
4 vs. Group 1), lower peak exercise VO2 (Group 1: 13.9 6
3.7; 2: 13.7 6 3.4, 3: 11.8 6 2.4; 4: 11.5 6 2.6 ml/min/kg,
p , 0.01 Groups 3 and 4 vs. Group 1), and lower peak
exercise cardiac output (Group 1: 10.0 6 2.8; 2: 9.0 6 3.0;
3: 7.4 6 2.1; 4: 6.3 6 2.0 L/min, p , 0.05 Groups 2, 3 and
4 vs. Group 1) (Table 3; Fig. 1). However, pulmonary
hypertension was observed in patients with preserved exer-
cise capacity as well as in patients with severe exercise
intolerance. For example, 18% of the patients in this study
had peak exercise VO2 levels .16 ml/min/kg. In these
patients, 41% had PVR of 1.5–2.49 Wood Units, 5% had
pulmonary resistances of 2.5–3.49 Wood Units and 7% had
pulmonary resistance .3.5 Wood Units.
Pulmonary vascular resistance decreased significantly
with exercise in patients with severe pulmonary hyperten-
sion (Group 4) but increased significantly in patients with
normal PVR (Group 1) (Fig. 2).
Pulmonary wedge pressures decreased during exercise in
28% of the entire population (mean decrease 5 5 6
3 mm Hg), possibly reflecting impaired delivery of blood to
the left ventricle. Thirteen percent of the patients in Group
1 decreased their pulmonary wedge pressure with exercise as
compared with 22%, 29% and 36% in Groups 2, 3 and 4,
respectively (p 5 0.005). When compared with patients
who increased their pulmonary wedge pressure with exer-
cise, patients who exhibited a decrease in pulmonary wedge
pressure during exercise had significantly higher resting
PVR (3.65 6 2.14 vs. 2.25 6 1.36 Wood Units) and higher
right atrial pressures at peak exercise (13 6 7 vs. 9 6
7 mm Hg) (both p , 0.0001).
DISCUSSION
Pulmonary vascular resistance in normal individuals is ,1.5
Wood Units (8). During exercise, pulmonary pressures
increase as a function of increased blood flow. Cardiac
output, however, increases out of proportion to pulmonary
pressures, resulting in a drop in PVR.
In patients with longstanding heart failure and high
pulmonary wedge pressures, several histologic changes occur
that lead to initially reversible and then irreversible pulmo-
nary hypertension. These changes include medial hypertro-
phy, intimal and adventitial fibrosis and focal hemosiderosis
(6). Theoretically, these changes can impair flow through
the lungs and contribute to exercise intolerance in heart
failure.
To investigate the impact of PVR on exercise perfor-
mance in heart failure, we examined hemodynamic param-
eters at rest and during exercise in a large group of patients
referred to the Vanderbilt Heart Failure and Transplant
Programs. The patients in general had relatively severe
exercise intolerance, as evidenced by an average peak exer-
cise VO2 of 13.4 ml/min/kg. However, 16% of the patients
had peak VO2 levels .16 ml/min/kg, consistent with
Functional Class II exercise limitation.
Incidence of pulmonary hypertension. Seventy-two per-
cent of the patients studied had pulmonary hypertension
(.1.5 Wood Units), including 19% with severe pulmonary
hypertension (PVR .3.5 Wood Units). This frequency of
pulmonary hypertension is similar to that observed by
Costard-Jackle et al. (9) in 288 patients evaluated at
Stanford University Medical Center for heart transplanta-
Table 2. Resting and Peak Exercise Hemodynamics
Baseline
(mean 1 SD)
Peak Exercise
(mean 1 SD)
MBP (mm Hg) 86 6 11 95 6 16
RAP (mm Hg) 8 6 5 9 6 6
PA (mm Hg) 28 6 11 40 6 13
PCWP (mm Hg) 18 6 09 23 6 10
Cardiac output (L/min) 4.5 6 1.3 8.5 6 3.0
TPR (wood units) 7.06 6 4.28 5.54 6 3.06
PVR (wood units) 2.45 6 1.57 2.41 6 1.52
VO2 (ml/min/kg) 13.0 6 3.4
MBP 5 mean blood pressure; PA 5 pulmonary artery; PCWP 5 pulmonary capillary
wedge pressure; PVR 5 pulmonary vascular resistance; RAP 5 right atrial pressure;
TPE 5 total pulmonary resistance; VO2 5 peak oxygen consumption.
Table 1. Demographic and Clinical Characteristics
Overall
PVR (WU)
<1.5
PVR (WU)
1.5–2.49
PVR (WU)
2.5–3.49
PVR (WU)
>3.5 p
Age (yr) 52 1 10 49 6 12 53 6 09 52 6 10 53 6 11 NS
LVEF (%) 23 6 9 24 6 07 23 6 08 24 6 13 21 6 7 NS
NYHA %
2 34 36 31 33 35
3 44 45 41 44 43 NS
4 22 19 28 23 22
IHD (%) 51 49 55 50 52 NS
DCM (%) 49 51 45 50 48
DCM 5 dilated cardiomyopathy; IHD 5 ischemic heart disease; LVEF 5 left ventricular ejection fraction; NS 5 nonsignificant; NYHA 5 New York Heart Association
Classification; PVR 5 pulmonary vascular resistance; WU 5 Wood Units.
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tion. These investigators noted that approximately 79% of
their patients had pulmonary hypertension, with close to
35% having PVR .3.5 Wood Units.
This high incidence of pulmonary hypertension may
reflect a referral bias because patients with mild heart failure
are rarely referred to specialty heart failure and heart
transplantation programs. Nevertheless, these findings in-
dicate that pulmonary hypertension is an extremely com-
mon problem in patients with moderate to severe heart
failure. We also noted that some patients with relatively
mild exercise symptoms had pulmonary hypertension. For
example, 58 of the patients in our study had a peak exercise
VO2 .16 ml/min/kg, a level of exercise ability usually
associated with only mild exertional symptoms. In these
patients, 41% had PVRs of 1.5 to 2.49 Wood Units, 5% had
pulmonary resistances of 2.5 to 3.49 Wood Units and 7%
had pulmonary resistance .3.5 Wood Units. Therefore, the
absence of major exertional symptoms does not exclude the
possibility of severe pulmonary hypertension.
Effect of exercise on pulmonary resistance. During exer-
cise, PVR changed relatively little, despite an increase in
cardiac output. One might expect that an increase in cardiac
output and pulmonary flow during exercise would produce
pulmonary vasodilation, due to recruitment and distention
of the pulmonary vascular bed. Instead, we observed a
decrease in resistance in patients with high resting pulmo-
nary vascular resistance but an increase in patients with
normal resistance.
A similar response was noted by Janicki et al. (10). These
investigators observed that pulmonary resistance increased
by 0.22 Wood Units in patients with initial PVR ,1.5
Wood Units whereas pulmonary resistance decreased by 1.2
Wood Unit in patients with initial PVR .3.5 Wood Units.
The reason for this response is unclear, although the degree
of change in either direction is small and unlikely to be
physiologically important.
Effect of pulmonary hypertension on exercise perfor-
mance. Does the presence of pulmonary hypertension im-
pair exercise performance? In this study, pulmonary hyper-
tension was associated with a reduced peak exercise VO2
and reduced cardiac output response to exercise, with the
degree of exercise abnormalities paralleling the degree of
Figure 1. Resting and peak exercise cardiac output in the patient
population (n 5 320). Figure 2. Effect of exercise on pulmonary vascular resistance.
Table 3. Comparison Between Patients With Normal and Increased PVR
Variable
PVR (WU)
<1.5
PVR (WU)
1.5–2.49
PVR (WU)
2.5–3.49
PVR (WU)
>3.5
P by
ANOVA
Rest MBP (mm Hg) 87 6 11 87 6 11 86 6 10 82 6 11** , 0.001
Peak exer MBP (mm Hg) 99 6 16 97 6 16 93 6 15 88 6 16** , 0.001
Rest RAP (mm Hg) 6 6 5 7 6 4 8 6 5 10 6 5** , 0.001
Peak exer RAP (mm Hg) 8 6 6 8 6 6 12 6 7** 12 6 6** , 0.001
Rest MPAP (mm Hg) 20 6 8 24 6 9* 33 6 9** 41 6 8** , 0.001
Peak exer MPAP (mm Hg) 34 6 11 38 6 12 44 6 11** 51 6 10** , 0.001
Rest PCWP (mm Hg) 14 6 8 15 6 9 21 6 9** 25 6 6** , 0.001
Peak exer PCWP (mm Hg) 21 6 11 21 6 11 24 6 10 27 6 8** 0.004
Rest CO (L/min) 5.2 6 1.3 4.6 6 1.0** 4.2 6 1.2** 3.3 6 0.7** , 0.001
Peak exer CO (L/min) 10.0 6 2.8 9.0 6 3.0* 7.4 6 2.1** 6.3 6 2.0** , 0.001
Change in CO (L/min) 4.8 6 2.4 4.4 6 2.5 3.2 6 1.7** 3.0 6 1.7** , 0.001
VO2 (ml/min/kg) 13.9 6 3.7 13.7 6 3.4 11.8 6 2.4** 11.5 6 2.6** , 0.001
*p , 0.05 vs. PVR , 1.5; **p , 0.01 vs. PVR , 1.5.
ANOVA 5 analysis of variance; CO 5 cardiac output; exer 5 exercise; MBP 5 mean blood pressure; MPAP 5 mean pulmonary artery pressure; PCWP 5 pulmonary
capillary wedge pressure; RAP 5 right atrial pressure; VO2 5 peak oxygen consumption.
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pulmonary hypertension. These findings are consistent with
an adverse effect of pulmonary hypertension on exercise
performance. In addition, we frequently observed a decrease
in the pulmonary wedge pressure during exercise in patients
with moderate to severe pulmonary hypertension, suggest-
ing impaired delivery of blood to the left ventricle. This
pattern was observed in 36% of patients with severe pulmo-
nary hypertension but only in 13% of patients with normal
PVR. Patients who exhibited a decrease in pulmonary
wedge pressure during exercise also had higher right atrial
pressures at peak exercise than other patients, consistent
with right ventricular failure.
It should be reiterated, however, that the presence of
pulmonary hypertension was not invariably associated with
major exercise intolerance, since over 50% of the patients
with peak exercise VO2 . 16 ml/min/kg had pulmonary
hypertension. Other factors, such as right ventricular func-
tion, likely modulate the impact of pulmonary hypertension
on cardiac output responses to exercise.
In summary, these observations suggest that pulmonary
hypertension is a very common problem in patients with
heart failure. These findings also provide suggestive evi-
dence that pulmonary hypertension contributes to exercise
intolerance in heart failure by impairing the cardiac output
response to exercise. However, it should be emphasized that
the presence of a relationship does not establish causality.
Additional studies are needed to determine the impact of
reducing PVR on exercise performance in heart failure.
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